Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors

Slični predmeti

• COX-2 selective inhibitors - they are still the best treatment for many patients!
  od: K Brune
  Izdano: (2005-03-01)
• The Effect of Selectivity of Inhibitors to Cox-2 Enzyme on Hepatobiliary and Platelet Function in Patients with Osteoarthritis
  od: Ali M. Hadi, i dr.
  Izdano: (2010-01-01)
• Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
  od: Wei Qi, i dr.
  Izdano: (2012-10-01)
• Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
  od: Pedro H. F. Araújo, i dr.
  Izdano: (2020-09-01)
• Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
  od: Afaf A. El-Malah, i dr.
  Izdano: (2022-07-01)